Sabra Health Care REIT (SBRA) Cash & Equivalents (2010 - 2026)

Sabra Health Care REIT's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $116.5 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 414.41% year-over-year to $116.5 million; the TTM figure through Mar 2026 stood at $116.5 million (up 414.41% YoY), while the FY2025 annual figure was $71.5 million, up 18.31% from the prior year.
• Cash & Equivalents was $116.5 million for Q1 2026 at Sabra Health Care REIT, up from $71.5 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $200.6 million in Q3 2025 to a low of $22.7 million in Q1 2025.
• Historically, Cash & Equivalents has averaged $60.5 million across 5 years, with a median of $49.3 million in 2022.
• The sharpest annual moves came in 2022 and 2026: Cash & Equivalents tumbled 95.19% in 2022, then soared 414.41% in 2026.
• A 5-year view of Cash & Equivalents shows it stood at $49.3 million in 2022, then retreated by 16.27% to $41.3 million in 2023, then surged by 46.46% to $60.5 million in 2024, then increased by 18.31% to $71.5 million in 2025, then soared by 62.89% to $116.5 million in 2026.
• The last three Cash & Equivalents figures came in at $116.5 million (Q1 2026), $71.5 million (Q4 2025), and $200.6 million (Q3 2025), per Business Quant data.